Showing 241-260 of 746 for: Cochrane Systematic Reviews > Pharmacotherapeutics 
- Corticosteroids for treating nerve damage in leprosy
Cochrane Systematic Reviews, 23-May-2016
Leprosy causes nerve damage that can result in nerve function impairment and disability. Corticosteroids are commonly used for treating nerve damage, although their long-term effect is uncertain. This is an update of a review first published in 2007, and
- Corticosteroids for treating optic neuritis
Cochrane Systematic Reviews, 14-Aug-2015
Optic neuritis is an inflammatory disease of the optic nerve. It usually presents with an abrupt loss of vision and recovery of vision is almost never complete. It occurs more commonly in women than in men. Closely linked in pathogenesis, optic neuritis m
- Corticosteroids for treating sepsis in children and adults
Cochrane Systematic Reviews, 6-Dec-2019
Sepsis occurs when an infection is complicated by organ failure. Sepsis may be complicated by impaired corticosteroid metabolism. Thus, providing corticosteroids may benefit patients. The original review was published in 2004 and was updated in 2010 and 2
- Corticosteroids for tuberculous pleurisy
Cochrane Systematic Reviews, 14-Mar-2017
Corticosteroids used in addition to antituberculous therapy have been reported to benefit people with tuberculous pleurisy. However, research findings are inconsistent and raise doubt as to whether such treatment is worthwhile. There is also concern regar
- Corticosteroids for viral myocarditis
Cochrane Systematic Reviews, 18-Oct-2013
Myocarditis is defined as inflammation of the myocardium accompanied by myocellular necrosis. Experimental evidence suggests that autoimmune mechanisms follow viral infection, resulting in inflammation and necrosis in the myocardium. However, the use of c
- Corticosteroids including ACTH for childhood epilepsy other than epileptic spasms
Cochrane Systematic Reviews, 18-Jun-2015
This is an updated version of the original Cochrane review published in Issue 1, 2007.
- Corticosteroids or ACTH for acute exacerbations in multiple sclerosis
Cochrane Systematic Reviews, 12-Nov-2013
Corticosteroids are commonly used to improve the rate of recovery from acute exacerbation in multiple sclerosis (MS) patients. However, it is unclear just how effective these agents are and which is the best treatment schedule (type of drug, dose, frequen
- Cotrimoxazole prophylaxis for opportunistic infections in adults with HIV
Cochrane Systematic Reviews, 21-Jul-2003
The prevention and early treatment of infections are the mainstay of the medical management of the majority of people with HIV infection, who live in low income countries without access to antiretroviral drugs. Cotrimoxazole is cheap and effective against
- Cyclical progestogens for heavy menstrual bleeding
Cochrane Systematic Reviews, 14-Aug-2019
Heavy menstrual bleeding (HMB) is a menstrual blood loss perceived by women as excessive that affects the health of women of reproductive age, interfering with their physical, emotional, social and material quality of life. Whilst abnormal menstrual bleed
- Cyclo‐oxygenase (COX) inhibitors for treating preterm labour
Cochrane Systematic Reviews, 5-Jun-2015
Preterm birth is a major cause of perinatal mortality and morbidity. Cyclo-oxygenase (COX) inhibitors inhibit uterine contractions, are easily administered and appear to have few maternal side effects. However, adverse effects have been reported in the fe
- Cyclosporin A for primary biliary cirrhosis
Cochrane Systematic Reviews, 16-Oct-2008
Cyclosporin A has been used for patients with primary biliary cirrhosis, but the therapeutic responses in randomised clinical trials have been heterogeneous.
- Cyclosporin as an oral corticosteroid sparing agent in stable asthma
Cochrane Systematic Reviews, 23-Oct-2000
Patients with chronic severe asthma are often dependent on the long term prescription of oral corticosteroids. The use of steroids is associated with serious side effects. Physicians treating such patients continue to search for alternative therapies that
- Danazol for heavy menstrual bleeding
Cochrane Systematic Reviews, 18-Jul-2007
Heavy menstrual bleeding (HMB) is an important cause of ill health in pre menopausal women. Medical therapy, with the avoidance of possibly unnecessary surgery is an attractive treatment option, but there is considerable variation in practice and uncertai
- Dapsone as an oral corticosteroid sparing agent for asthma
Cochrane Systematic Reviews, 21-Oct-2002
Oral corticosteroids are used as a treatment for asthma, however they are often associated with serious side effects. Dapsone is a sulfone with anti-inflammatory properties, therefore it may have a beneficial effect in the treatment of asthma and act as a
- Dehydroepiandrosterone for systemic lupus erythematosus
Cochrane Systematic Reviews, 15-Sep-2008
Systemic lupus erythematosus (SLE) is a chronic inflammatory, multisystem autoimmune condition. Dehydroepiandrosterone (DHEA) is a naturally occurring inactive steroid which may possess disease activity modifying properties as well as the ability to reduc
- Depot fluspirilene for schizophrenia
Cochrane Systematic Reviews, 24-Jan-2007
Antipsychotic drugs are the mainstay treatment for schizophrenia and similar psychotic disorders. Long-acting depot injections of drugs such as fluspirilene are extensively used as a means of long-term maintenance treatment.
- Depot haloperidol decanoate for schizophrenia
Cochrane Systematic Reviews, 25-Jan-1999
The mainstay of treatment for schizophrenia is the antipsychotic group of drugs. These are usually given orally but compliance with medication given by this route may be difficult to quantify. Problems with treatment adherence are common. The development
- Depot perphenazine decanoate and enanthate for schizophrenia
Cochrane Systematic Reviews, 20-Jul-2005
Antipsychotic drugs are usually given orally but compliance with medication given by this route may be difficult to quantify. The development of depot injections in the 1960s gave rise to extensive use of depots as a means of long-term maintenance treatme
- Depot pipotiazine palmitate and undecylenate for schizophrenia
Cochrane Systematic Reviews, 19-Jul-2004
Antipsychotic drugs are usually given orally but compliance may be problematic. The development of depot injections in the 1960s gave rise to their extensive use as a means of long-term maintenance treatment. Pipotiazine palmitate is a depot from the phen
- Desmopressin for nocturnal enuresis in children
Cochrane Systematic Reviews, 5-Nov-2008
Enuresis (bed-wetting) is a socially disruptive and stressful condition which affects from 15% to 20% of five year olds, and up to 2% of young adults.
